Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

NCT04666649 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Relapsed or Refractory Acute Myeloid Leukemia

Interventions

DRUG: Venetoclax and pegcrisantaspase

Sponsor

University of Maryland, Baltimore